EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cellular senescence in cancer: Friend or fraud?

Qingxin Chen, Jianxin Liu, Jianming Wu, Xin Xiang, Xiaogang Zhou, Jianing Mi, Jing Wei, Xiao Zou, Anguo Wu

Drug Resistance Updates · 2026-05 · 86 · 101363

DOI: 10.1016/j.drup.2026.101363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2026-05. Verfasst von Qingxin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Department of Cardiology, the Affiliated Hospital of Southwest Medic…. Hauptthemen laut MEDLINE: Neoplasms, Cellular Senescence, Senescence-Associated Secretory Phenotype. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 551 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China, Southwest Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence, a stress-induced state of stable cell cycle arrest accompanied by a senescence-associated secretory phenotype (SASP), plays a paradoxical role in cancer biology. On the one hand, senescent cells function as a barrier to tumor initiation by activating the DNA damage response (DDR) and tumor suppressor pathways such as p53/p21 and p16INK4a-retinoblastoma (RB). On the other hand, their long-term persistence promotes chronic inflammation, immune evasion, and tissue remodeling via sustained SASP, ultimately facilitating tumor progression, metastasis, and therapeutic resistance. This review elucidates the hallmarks of cellular senescence, explores its dual roles and mechanistic underpinnings in tumor suppression and promotion, highlighting the key molecular circuits governing the senescence phenotype, such as telomere dynamics, autophagy-lysosome function, and immunosurveillance. We further examine targeted therapeutic approaches, such as senolytics and senomorphics, and their integration into sequential induction and clearance regimens. These interventions aim to leverage the transient SASP to enhance immune recognition while minimizing the pro-tumorigenic effects associated with persistent SASP. Despite these advances, challenges such as tissue specificity, off-target effects, biomarker inconsistency, and cellular heterogeneity remain major hurdles to clinical translation. To transcend the traditional static and binary perspective of senescence, we introduce a dynamic plasticity model that conceptualizes senescence as a context-dependent and dynamically regulated program, potentially reversible and modulated by molecular switches, temporal patterns of SASP, and microenvironmental factors. Targeting these plasticity checkpoints holds promise for optimizing "one-two punch" combination regimens and expanding immunotherapeutic windows, thereby offering a novel paradigm for improving outcomes in aging-related cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCellular SenescenceSenescence-Associated Secretory PhenotypeHumansAnimalsAntineoplastic AgentsAutophagySenotherapeuticsDNA DamageTumor Microenvironment

Stichwörter der Autor:innen

Cancer stemnessCellular senescenceImmune surveillanceSenescence-associated secretory phenotypeSenolytic therapySenomorphic therapyTherapy-induced senescenceTumor microenvironment

Substanzen

Antineoplastic AgentsSenotherapeutics

Autor:innen und Institutionen

  • Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Department of Cardiology, the Affiliated Hospital of Southwest Medical University and Key Laboratory of Medical Electrophysiology, Southwe…
  • School of Pharmaceutical Sciences, Sino-Pakistan Center on Traditional Chinese Medicine, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province,…
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China. Electronic address: mjnrhw@hotmail.com.
  • Department of Ophthalmology, The Affiliated Hospital, Southwest Medical University, Sichuan, Luzhou 646000, China. Electronic address: weijingzhuzhu@swmu.edu.cn.
  • Department of Pharmacy, Sichuan Provincial People's Hospital Wenjiang Hospital, Sichuan, Chengdu 611130, China. Electronic address: zouxiao@wj120.com.cn.

Förderung

  • Natural Science Foundation of Sichuan Province
  • National Natural Science Foundation of China
  • Southwest Medical University
  • China Postdoctoral Science Foundation
  • China Academy of Chinese Medical Sciences

Zitieren

APA

Chen, Q., Liu, J., Wu, J., Xiang, X., Zhou, X., Mi, J., Wei, J., Zou, X., & Wu, A. (2026). Cellular senescence in cancer: Friend or fraud?. Drug Resistance Updates, 86, 101363. https://doi.org/10.1016/j.drup.2026.101363

Vancouver

Chen Q, Liu J, Wu J, Xiang X, Zhou X, Mi J, et al. Cellular senescence in cancer: Friend or fraud?. Drug Resistance Updates. 2026;86:101363. doi:10.1016/j.drup.2026.101363

BibTeX
@article{Chen2026,
  author = {Chen, Qingxin and Liu, Jianxin and Wu, Jianming and Xiang, Xin and Zhou, Xiaogang and Mi, Jianing and Wei, Jing and Zou, Xiao and Wu, Anguo},
  title = {Cellular senescence in cancer: Friend or fraud?},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {86},
  pages = {101363},
  doi = {10.1016/j.drup.2026.101363}
}
Kostenlos starten →